Inotuzumab ozogamicin
From Wikipedia, the free encyclopedia
Inotuzumab ozogamicin?
|
|
Therapeutic monoclonal antibody | |
Source | Humanized |
Target | CD22 |
Identifiers | |
CAS number | |
ATC code | ? |
PubChem | ? |
Chemical data | |
Formula | C6518H10002N1738O2036S42 |
Mol. mass | ? |
Pharmacokinetic data | |
Bioavailability | ? |
Metabolism | ? |
Half life | ? |
Excretion | ? |
Therapeutic considerations | |
Pregnancy cat. |
? |
Legal status | |
Routes | ? |
Inotuzumab ozogamicin is a humanized monoclonal antibody and which is used to treat cancers. Inotuzumab has a chelator, ozogamicin, same as in gemtuzumab.
|